Human leukocyte antigens (HLA) class II antigenmediated apoptosis has been documented in antigenpresenting cells and B lymphoproliferations. Characteristics of the apoptosis include rapidity and selectivity for mature cells. Follicular lymphomas are particularly refractory to apoptosis. The B-cell lymphoma Ramos shares characteristics of this subgroup and is insensitive to apoptosis via simple HLA-DR engagement. However, oligomerization of HLA-DR antigens induced caspase activation followed by phosphatidylserine externalization, activation of PKC-d and cleavage of nuclear lamin B. Mitochondrial injury was also detected. However, inhibition of caspase activation simply delayed the apoptotic phenotype but neither protected against cell death nor prevented mitochondrial injury. The data in this report demonstrate that the requirements for the initiating signal (oligomerization versus engagement) as well as the molecular pathways varies between different B lymphoproliferations despite their common expression of HLA-DR. Finally, blockade of caspase activation in parallel with HLA-DR mAb stimulation could provide a potent autovaccination stimulus by leading to necrotic death of B-cell lymphomas.
Introduction
Apoptosis is a key regulatory mechanism of the immune system and occurs during both lymphopoiesis and immunopoiesis in order to maintain tolerance toward self and to control the specificity of the immune response. Lymphocyte homeostasis is assured by apoptosis via cell surface receptors including the B-and the T-cell antigen receptors (Green and Scott, 1994) . Apoptosis of human B cells via membrane receptors underlies the recent development of potent therapeutic tools based on mAbs directed against the CD20 surface molecule (Pedersen et al., 2002) . The Human leukocyte antigens (HLA) class II antigens are constitutively expressed throughout B-lymphocyte ontogeny and initiation of a cell death pathway following simple engagement of HLA-DR has been widely reported (Drenou et al., 1999; Leveille et al., 1999) .
One of the earliest events following engagement of HLA class II antigens is the activation of the serine/ threonine kinase protein kinase C (PKC) family of isoenzymes (Brick-Ghannam et al., 1991; Brick-Ghannam et al., 1994) and we have previously shown that truncation of the beta chain of the HLA-DR molecule abrogates HLA-DR-mediated activation of PKC (Rich et al., 1997) . The atypical PKC-d isoenzyme has been implicated in diverse apoptotic pathways (Scheel-Toellner et al., 1999; Webb et al., 2000) . Studies in PKC-ddeficient mice revealed maturation of self-reactive B cells, production of autoantibodies and increased numbers of B lymphocytes suggesting a role for PKCd as a negative regulator of B-cell proliferation (Mecklenbrauker et al., 2002; Miyamoto et al., 2002) . PKC-d can be activated by lipid cofactors and cleavage in the V3 hinge region by caspase-3, leading to release of the 40 kDa catalytic fragment, has been reported during apoptosis (Emoto et al., 1995; Ghayur et al., 1996) . This mode of activation appears to be required for PKC-d to effect its proapoptotic actions.
Development of ligands of the HLA-DR molecule is of therapeutic interest for the treatment of B lymphoproliferations and a humanized HLA-DRmAb can concurrently provide cell survival and apoptosis signals in B-chronic lymphocytic leukaemia (B-CLL) (Mone et al., 2004) . The Epstein-Barr virus (EBV)-negative Ramos B-cell line has characteristics of germinal centre lymphocytes as it undergoes B-cell antigen receptorinduced apoptosis but is resistant to Fas-mediated apoptosis unless prestimulated via CD40. We have studied HLA-DR-mediated death of Ramos and of primary follicular lymphomas and show that oligomerization of HLA-DR leads to (i) caspase activation followed by PKC-d cleavage in the nucleus and the mitochondria as well as lamin B phosphorylation and cleavage, (ii) this process was associated with mitochondrial injury. Finally, our data reveal that caspase activation is dispensable for this form of cell death.
Results

HLA-DR oligomerization is required for apoptosis
The nonblastic Ramos B-cell lymphoma has been described as resistant to apoptosis induced by addition of HLA-DR mAb (Leveille et al., 1999) whereas Blymphoblastic cell lines and primary B-cell CLL undergo rapid apoptosis (Truman et al., 1996; Drenou et al., 1999; Nagy et al., 2002) . However, Chaouchi et al. (1995) have shown that crosslinking is an essential step to induce apoptosis in Ramos via either the CD19 or CD22 surface receptors. We therefore examined cell death after oligomerization by addition of HLA-DR mAb followed by a crosslinking Ig. Apoptosis was detected by both a plasma membrane readout; phosphatidylserine externalization and by mitochondrial transmembrane potential fall. A high concentration of CHX was used as a broad spectrum apoptosis-inducing stimulus. Figure 1 shows that soluble HLA-DR mAb binding (L243) did not induce apoptosis whereas oligomerization of HLA-DR (L243 þ GAM) led to a dramatic increase in the level of Annexin-V binding in around 50% of B lymphocytes compared with 10% in nonstimulated cells (Figure 1a) .
The corresponding dot-plots are shown in Figure 1b . A clear increase in both the Annexin-V þ population and in the Annexin-V þ /7-AAD þ population was observed after HLA-DR crosslinking. HLA-DR oligomerization particularly increased the Annexin-V þ population more than the 7-AAD þ /Annexin-V þ population. Since the Annexin-V þ phenotype cells is considered representative of 'classical' apoptosis whereas Annexin-V þ /7-AAD þ positive is considered representative of death by necrosis, these data indicated a classical apoptotic pathway. Mitochondrial injury was assessed by DiOC 6 staining and Figure 1c shows a typical profile of the decrease in DCm induced by HLA-DR oligomerization. In contrast, neither the simple engagement of the HLA-DR molecules nor the crosslinking of a control Ig induced mitochondrial injury. The time course of mitochondrial injury compared with phosphatidylserine externalization was determined and Figure 1d shows that an increase in the Annexin V-positive population was detected at the same time as the DiOC 6 low population (after 4 h). Both Annexin V high and DiOC 6 low cells continued to increase for up to 18 h after which no further increases were observed in either population.
Oligomerization of HLA-DR leads to caspase activation in the Ramos B lymphoma Caspase-8 has been identified as the most membrane proximal caspase and is recruited to the death inducing signalling complex of the TNF receptor family by its unique DED (Medema et al., 1997) . However, activation of caspase-8 has also been described independently of death domain receptors or FADD and could be mediated by postmitochondrial caspase-3 activation (Inman and Allday, 2000b; Wieder et al., 2001) . Figure 2a shows that crosslinking of HLA-DR induces caspase-8 enzymatic activity comparable with that induced by IgM or by the combination of CD40 and Fas antibodies. Similarly to apoptosis, HLA-DR mAb binding to Ramos B cells without crosslinking did not activate caspase-8.
Like many caspases, activation of caspase-8 is dependent upon cleavage of the proform. Caspase-8 is synthetized as two isoforms of 55 and 54 kDa, which can be cleaved to intermediate 43 and 41 kDa fragments and then further processed. Immunoblotting revealed cleavage of caspase-8 to the 43 and 41 kDa fragments either after HLA-DR oligomerization, BCR stimulation or the combination of CD40 Ab and Fas Ab (Figure 2b ). Quantification of the cleavage of the full-length caspase-8 protein band is shown. This immunoblot approach confirmed that soluble mAb binding to HLA-DR was insufficient for caspase-8 activation.
We then examined the time course of cleavage of both the initiator caspase-8 and the effector caspase-3. Following HLA-DR oligomerization, both were cleaved within 12 h ( Figure 2c ) indicating simultaneous activation.
HLA-DR-mediated induction of apoptosis in primary follicular lymphomas All of the above data were obtained from experiments using the Ramos B lymphoma. We next examined whether HLA-DR oligomerization could also induce apoptosis in primary lymphomas of germinal centre origin and whether caspase activation was initiated. Samples from five patients with well-characterized follicular small cell non-Hodgkin's lymphoma were examined. The data in Table 1 reveal an increase in the proportion of apoptotic cells (Annexin V þ /7AAD À ). Caspase-3 activation as assessed using a mAb was in a similar range. However, the data revealed that primary B-cell lymphomas also display a necrotic-like phenotype (Annexin V þ /7AAD þ ) and that in fact the extent of the mitochondrial injury as assessed by using the DiOC 6 probe corresponds to the sum of both the apoptotic and the necrotic-like cells. We have not formally excluded the possibility of induction of a separate Annexin V À /DiOC 6 low population although the time course in Figure 1d reveals that phosphatidylserine externalization and mitochondrial injury are detected simultaneously after HLA-DR oligomerization. Moreover, when the DiOC 6 low population was gated, it corresponded to an Annexin V þ population, it is therefore unlikely that an Annexin V À /DiOC 6 low population is induced by oligomerization of HLA-DR. HLA-DR crosslinking leads to PKC-d and relocalization of activated PKC to nuclear and mitochondrial compartments PKC-d cleavage, indicating activation, which has been widely implicated in apoptosis was examined. Cleavage was detected within the same timeframe as caspase activation (12 h) after HLA-DR oligomerization ( Figure 3a) . We next determined the site of localization of the full length and the cleavage product following crosslinking of HLA-DR antigens. Figure 3b shows that full-length PKC-d was detected in the cytosolic, nuclear and mitochondrial fractions isolated from unstimulated B lymphocytes whereas the cleaved form was detected in the nuclear and mitochondrial fractions after stimulation. Crosslinking of control IgG2a did not lead to cleavage of PKC-d (data not shown).
HLA-DR crosslinking leads to cleavage of lamin B
Lamin B dissociation plays a role in nuclear disintegration events during apoptosis and phosphorylation of lamin B by the PKC-d iso-enzyme precedes nuclear lamin breakdown (Cross et al., 2000) . Mediators of the nuclear events occurring in HLA-DR-mediated death have not been identified (Lazebnik et al., 1993) . Figure 3c shows that the full-length form of lamin B (70 kDa) was detected in Ramos lysates. A time course of HLA-DR crosslinking revealed lamin B cleavage after 12 h (cleaved fragment at 46 kDa). Disintegration of the nuclear lamin B is therefore initiated via HLA-DR oligomerization.
We metabolically labelled B lymphocytes with (P 32 )-orthophosphosphate before crosslinking HLA-DR. Lamin B was immunoprecipitated and phosphorylation was detected by autoradiography. Figure 3d reveals that crosslinking of HLA-DR led to phosphorylation of full-length lamin B.
Inhibition of caspase activation does not protect from HLA-DR-mediated cell death We determined the actual survival of Ramos following HLA-DR crosslinking by counting live cells. Figure 4a shows that the number of live cells was sharply decreased after HLA-DR ligand crosslinking compared with nonstimulated cells. However, the caspase inhibitors z-IETD and z-VAD failed to improve cell survival after either 18 or 40 h of incubation with the HLA-DR mAb. Similarly, the scatter plots in Figure 4b shows that whereas oligomerization of HLA-DR leads to cell shrinkage (decreased FSC) and increased granularity (increased SSC), these were unaltered in the presence of either z-IETD or z-VAD and that caspase inhibition did not therefore protect from cell death. These data were confirmed using another cell permeable and irreversible inhibitor cpm-VAD-CHO. We also used a cathepsin L inhibitor to determine whether this protease was implicated in either the Annexin V externalization or the mitochondrial damage, inhibition of cathepsin L Time ( HLA-DR cell death pathway in follicular lymphoma M Carmagnat et al failed to protect against mitochondrial damage or phosphatidylserine externalization (data not shown).
Finally, despite a slight decrease in the proportion of Annexin V þ /7AAD À cells after stimulation via HLA-DR, after 40 h most of the Ramos cells display in fact a necrotic 7AAD
þ Annexin V þ phenotype. Preincubation of the primary B-cell lymphomas with the same concentrations of the caspase inhibitors also failed to significantly inhibit phosphatidylserine exposure and to protect the cell from death (Figure 4c) We then examined the impact of caspase inhibition on mitochondrial injury. While, as described above, caspase inhibition at 18 h decreased phosphatidylserine exposure, Figure 4d shows that DCm loss via HLA-DR was unaltered by caspase inhibition. In contrast, IgMmediated DCm loss was inhibited by both z-IETD-fmk and by z-VAD-fmk.
PKC-d and lamin B cleavage are dependent on caspase activation
We used cell permeable and irreversible tetrapeptide caspase inhibitors to determine whether caspase activation was upstream of PKC-d and lamin B cleavage. Pretreatment with either z-IETD or z-VAD or z-DEVD completely inhibited both PKC-d and lamin B cleavage, as well as caspase-8 activation ( Figure 5 ) despite a similar level of cell death and mitochondrial injury (see Figure 4 ). These data support the idea that cleavage of PKC-d is a caspase-dependent event. and mature dendritic cells (Funakoshi et al., 1997; McLellan et al., 2000; Setterblad et al., 2004) . The current study reveals the potential of HLA-DR mAbs to induce cell death of germinal centre follicular lymphomas and in the Ramos B-lymphoma cell line. This is the first description of a requirement for oligomerization rather than simple engagement of the HLA-DR antigens in order to induce cell death. Similarly to HLA-DR, apoptosis of Ramos B cells is induced via CD19 and CD22 only after extensive crosslinking (Chaouchi et al., 1995) although the basis for the requirement for oligomerization is unclear. Expression levels of HLA-DR molecules do not differ in Ramos compared with B lymphoblasts sensitive to apoptosis with soluble HLA-DR mAb alone. Oligomerization of HLA-DR in the THP-1 myelomonocytic cell line led to recruitment of HLA-DR molecules to lipid rafts and this localization was essential for recruitment and activation of tyrosine kinases (Huby et al., 1999) . However, disruption of cholesterol-dependent lipid rafts did not alter cell death mediated by HLA-DR oligomerization in this model (data not shown). Nonetheless the requirement for oligomerization suggests that a threshold for activation of apoptosis signalling must be attained in the Ramos lymphoma.
Discussion
HLA-DR-mediated apoptosis has been described in EBV-transformed B cells, certain B lymphoproliferations
Our data show that HLA-DR oligomerization led to the loss of DCm and activation of caspase-8 independently of expression of the CD95/Fas molecule. A previous study addressed the question of a MHC class II-mediated apoptosis in murine dendritic cells and reported that both a membrane associated and a mitochondrial pathway were involved since cells were not protected from death by overexpression of Bcl-2 (Leverkus et al., 2003) . Caspase-8 activation was initially believed to be dependent upon ligation of death receptors, however, examples of nondeath receptormediated activation of caspase-8 have been reported (Inman and Allday, 2000a; Besnault et al., 2001) . Caspase-3 and -8 activation were concomitant and this could be due to activation of an amplification loop rather than a linear caspase-activation cascade model.
Nonetheless the final outcome of the observed caspase activation has a more important role in the death phenotype rather than in regulating cell death.
PKC-d has been attributed a proapoptotic role in diverse models of apoptosis and overexpression of the catalytically active fragment cleaved by caspase-3 is sufficient to induce apoptosis (Emoto et al., 1995; Ghayur et al., 1996) . In other models, either the mitochondrial translocation of full-length PKC-d was necessary and sufficient to activate cell death, or translocation of full-length PKC-d to the nucleus was observed (Majumder et al., 2000; Cross et al., 2000) . HLA-DR oligomerization induced PKC-d cleavage that was observed in the nuclear and mitochondrial fractions. These data also provide the first description of lamin B as a nuclear target of HLA-DR signalling. However, since both PKC-d activation and lamin B cleavage are in fact downstream events of caspase activation, they may only have a minimal role in the cascade of events leading to death since although caspase inhibition prevented PKC-d and lamin B cleavage, cell survival was not improved. With regard to the potential involvement of other kinases, we particularly examined ERK and MEK and did not observe activation of either despite clear activation via the BCR in these cells (data not shown).
This HLA-DR-mediated cell death pathway is therefore distinct from previously described pathways in lymphoblastic B-cell lines and in B-CLL in terms of both the requirement for oligomerization and the caspase activation, caspase-3 activation was specifically excluded in a previous study (Drenou et al., 1999) . The need for oligomerization suggests that the cytoskeleton could have a regulatory role for cell death in the Ramos lymphoma as has been previously proposed in dendritic cells (Leverkus et al., 2003) .
Mitochondrial injury (which corresponded to the sum of necrotic and apoptotic events) in small cell follicular lymphomas and both phosphatidylserine exposure and caspase-3 activation were clearly induced via HLA-DR. Unlike the Ramos lymphoma, phosphatidylserine exposure was not delayed in the presence of caspase inhibitors when primary cells were studied. The resistance of the primary follicular lymphomas to apoptotic signals in general is underlined by the failure of even a high concentration of CHX to induce significant apoptosis.
A recent study using humanized HLA-DR mAbs in an in vivo primate model confirmed the clinical potential of HLA-DR mAbs in lymphoid malignancies firstly because of the reduced tumour development and secondly because of the extremely short-lived impact on haematopoiesis (Nagy et al., 2002) . Although the use of engineered Abs as therapeutic tools for the control of lymphoproliferative disease is very promising, our data underline the necessity to dissect the molecular events leading to cell death and ultimately the therapeutic outcome in order to identify new targets for intervention.
Whereas apoptosis is generally considered as a tolerogenic signal, late apoptotic dying cells or necrotic cells are considered potently immunogenic (Edinger and Thompson, 2004) . Therefore, our observation that zVAD-fmk delays HLA-DR-mediated phosphatidylserine exposure and leads to a necrotic phenomenon could be a potential therapeutic tool for the control of the growth of B-cell lymphomas. Moreover, a strategy based on the use of HLA-DR antibodies in association with caspase inhibitors may represent a novel approach by inducing an 'auto vaccination'.
Materials and methods
Reagents HLA-DR mAb L243 was purified from ascitic fluid. Goat antimouse Ab (GAM) was purchased from Southern Biotechnology Associates Inc. Anti-IgM is a affinipure F(ab) 0 2 fragment donkey anti-human IgM (Jackson ImmunoResearch Laboratories Inc.). Mouse IgG2a isotype control (UPC 10) was from Sigma Biosciences. Fas antibody (7C11) was from Immunotech. CD40 (G28.5) mAb was purified from ascites of hybridoma cells obtained from the American Type Culture Collection (ATCC) (Rockville, MD, USA). Cycloheximide (CHX) was from Sigma.
Cell permeable tetrapeptide caspase inhibitors z-DEVDfmk, z-VAD-fmk, z-IETD-fmk and cpm-VAD-CHO were from Calbiochem. The cell permeable and reversible Cathepsin L inhibitor z-FF-FMP was also from Calbiochem. Working solutions of 100 mM were prepared immediately before use and cells were preincubated with the inhibitors (concentrations as indicated) for 45 min.
Cell culture
Ramos B cells are an EBV-negative Burkitt's lymphoma (ATCC) and were cultured in RPMI 1640 containing 10% fetal calf serum, 2 mM L-glutamine, 100 U/ml penicillin and 100 mg/ml streptomycin.
Primary follicular lymphomas
Primary follicular lymphomas from five patients were characterized by PCR at the major or minor breakpoint of the rearrangement between the Bcl2 gene and the JH region of the immunoglobulin heavy chain gene (REAL/WHO classification). All (n ¼ 5) were of germinal centre origin and contained more than 80% of tumour cells.
Induction and assessment of apoptosis B cells were incubated at 2 Â 10 6 /ml, with the following antibodies and drugs: L243 (5 mg/ml), BCR Ab (10 mg/ml), anti-Fas (1 mg/ml), anti-CD40 (1 mg/ml), IgG2a isotype control (5 mg/ml), IgM isotype control (1 mg/ml), CHX (5 mg/ml) for 18 h unless otherwise indicated. The GAM crosslinking Ig was used at 20 mg/ml.
Annexin V binding and exclusion of 7-aminoactinomycin D (7-AAD) was detected according to the manufacturer's instruction (R&D systems) before analysing samples on a FACScan flow cytometer (Becton Dickinson Immunocytometry Systems (BDIS), San Jose, CA, USA).
Mitochondrial transmembrane potential (DCm)
To evaluate changes in DCm, 2 Â 10 6 cells/ml were labelled with dihexylocarbocyanine iodide (DiOC 6 , Molecular Probes, Leiden, The Netherlands) at 23 ng/ml for 15 min at 371C. Cells were washed and analysed directly on a flow cytometer using excitation and emission wavelengths of 495 and 525 nm, respectively.
Assay of caspase activity Caspase-8 activity was determined using a colorimetric substrate cleavage assay (R&D Systems). Cells were incubated with L243 or control IgG2a before lysis. Caspase-8 IETDpNA was added to the cell lysate in a final volume of 100 ml in 96-well plates. Plates were incubated for 2 h at 371C and ODs were measured at a wavelengh of 405 nm. Results are expressed as fold increase in caspase activity in stimulated cells, using unstimulated cells as the reference.
FITC-conjugated caspase-3 mAb was used to detect active caspase-3 by flow cytometry (BD Biosciences).
Preparation of nuclear, mitochondria, and cytosol-enriched fractions Cells were lysed in hypotonic buffer (20 mM Tris pH7.4, 2 mM MgCl 2 , 10mM EGTA, 2 mM EDTA, 2 mM DTT) and centrifuged at 800 g for 10 min to sediment nuclei, further centrifuged at 10 000 g for 45 min to sediment the mitochondrial fraction and finally at 100 000 g for 45 min to isolate cytosol (supernatant)-enriched fractions. The pellet was solubilized in hypotonic buffer with 1% Triton-X 100 and the membrane (supernatant) and cytoskeletal (pellet)-enriched fractions were separated after a centrifugation at 100 000 g for 45 min. Each fraction was taken up in Laemmli SDS sample buffer and heated for 5 min at 1001C. The enrichment of subcellular fractions was verified using appropriate marker proteins (data not shown).
Western blot analysis Cells were lysed in modified Laemmli buffer (60 mM Tris pH 6.8, 10% glycerol and 2% SDS) without b-mercapthethanol and bromophenol blue and sonicated for 15 s on ice before centrifugation for 20 min at 20 000 g. Aliquots of the supernatants were used to measure protein concentration (Bradford, Biorad). b-Mercaptoethanol and bromophenol blue were added and cell lysates (20 mg/lane) were resolved by SDS-PAGE before transfer and immunoblotting of caspase-8 (12F5, Alexis Biochemicals), caspase-3 (BD Biosciences), PKC-d (C-20, Santa Cruz Biotechnology) or lamin B (provided by Dr N Chaudhary).
Phosphorylation assays 20 Â 10 6 cells were metabolically labelled with 0.2 mCi/ml ( 32 P) orthophosphate for 4 h in phosphate-free medium, then stimulated via HLA-DR. Cells were lysed in 20 mM Tris-HCL, pH 7.4 containing 1% NP-40 and protease inhibitors. Lamin B was immunoprecipited with a rabbit anti-lamin B antibody (Dr N Chaudhary) separated on 10% SDS-PAGE, transferred to membranes and autoradiographed on Amersham films for 72 h at À201C.
Cell viability assay
Cell viability was assessed by Trypan blue exclusion (0.1% final concentration), at 18 and 40 h after cell stimulation. Live cells were counted under a light microscope.
